Company
Melbourne, VIC
Every investor coverage indicates participated in a round Neurala Biosciences raised.
Investors whose own portfolio pages list Neurala Biosciences, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Tin Alley Ventures | its portfolio page ↗ |
Companies Neurala Biosciences acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Neurala Biosciences. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Melbourne-based biotech Neurala Biosciences, founded by two researchers turning DMT and harmala compounds into medicines, covering its origins, grant and investor backing totalling $4.5m, and planned first-in-human studies.